GRI Bio's total assets for Q3 2024 were $5.46M, a decrease of -22.36% from the previous quarter. GRI total liabilities were $1.80M for the fiscal quarter, a -22.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.